Sescon, Erika Alice L.
HRN: 00-13-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2025
10/17/2025
IV
500 Mg
Q8hrs
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes